PT - JOURNAL ARTICLE AU - Ruiz, Milton Artur AU - Kaiser Junior, Roberto Luiz AU - Piron-Ruiz, Lilian AU - Pinho, Tainara Souza AU - Castiglioni, Lilian AU - de Quadros, Luiz Gustavo TI - COVID-19 Impact in Crohn’s Disease Patients Underwent Autologous Hematopoietic Stem Cell Transplantation AID - 10.1101/2023.06.22.23291610 DP - 2023 Jan 01 TA - medRxiv PG - 2023.06.22.23291610 4099 - http://medrxiv.org/content/early/2023/06/28/2023.06.22.23291610.short 4100 - http://medrxiv.org/content/early/2023/06/28/2023.06.22.23291610.full AB - SARS COV 2 is the virus responsible for COVID-19, a disease that has been blamed for inducing or exacerbating symptoms in patients with autoimmune diseases.Crohn’s disease (CD) is an inflammatory bowel disease that affects genetically susceptible patients who develop an abnormal mucosal immune response to the intestinal microbiota. Patients who underwent Hematopoietic Stem cell Transplantation are considered at risk for COVID-19.The objective of this report was to describe for the first time the impact of COVID-19 in a group of 50 patients with Crohn’s Disease (CD, 28 females, and 22 male) with a mean age of 38 years, previously submitted to Autologous, non-myeloablative, Hematopoietic Stem Cell Transplantation (Auto HSCT) between 2013 and 2021. In this series, 19 patients were diagnosed with positive COVID-19. In two (2) patients there was a report of the occurrence of two infectious episodes. Parameters related to HSCT, such as time elapsed since the procedure, vaccination status, CD status before and after infection, and clinical manifestations resulting from COVID-19, were evaluated. Among the patients with COVID-19, in three, submitted to Auto HSCT less than six (6) months ago, there was a change in the CD status, and one of them, in addition to the CD symptoms, started to present thyroid impairment with positive anti-TPO. Only one of the patients required hospitalization for five days to treat COVID-19 and remained in CD clinical remission. Nine patients reported late symptoms that may be related to COVID-19. There were no deaths, and the statistical evaluation of the series of COVID-19 patients after HSCT and those who did not present an infectious episode did not present significant data regarding the analyzed parameters. Despite the change in CD status in three patients and the presence of nine patients with late symptoms, we can conclude that there was no significant adverse impact concerning COVID-19 in the evaluated patients who underwent HSCT to treat CD.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03000296 IRD-CAAE 20 894719.1.0000.5629Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Associacao Portuguesa de Beneficencia, Sao Jose do Rio Preto, SP, Brazil IRD-CAAE 20 894719.1.0000.5629 US Clinical Trials NCT03000296 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript